| Literature DB >> 30269135 |
Jason Ho1, Matthew Ware1, Justin Law1, Aaditya Nagaraj2, Shilpa Jain3, Jesse Rios4, Reynaldo Calderon5, Barry Toombs4, Andrew Anderson1,6, Collin Bray2, Steven Curley1,6, Stuart James Corr7,8,9,10,11.
Abstract
Large animal models are important tools for hepatocellular carcinoma (HCC) research, especially in studies of hepatic vasculature, interventional techniques, and radiofrequency or microwave hyperthermia. Currently, diethylnitrosamine (DENA)-induced HCC in pigs is the only large animal model for in situ HCC with a tumor latency of 10-26 months. While phenobarbital (PB) is often used to accelerate DENA-induced HCC in rodents, it has not been previously studied in the porcine model. Therefore, we hypothesize that the addition of PB in the DENA-induced HCC porcine model will accelerate tumor latency compared to DENA alone. HCC and benign lesions were seen on serial MRI and confirmed on histopathology. Liver and tumors were further characterized by CT angiography, vascular corrosion casting, and permittivity measurements.Entities:
Keywords: Diethylnitrosamine; Hepatocellular carcinoma; Phenobarbital; Porcine
Mesh:
Substances:
Year: 2018 PMID: 30269135 DOI: 10.1159/000491092
Source DB: PubMed Journal: Oncology ISSN: 0030-2414 Impact factor: 2.935